Caudalized human iPSC-derived neural progenitor cells produce neurons and glia but fail to restore function in an early chronic spinal cord injury model

Experimental Neurology

Volumn 248, Issue , 2013, Pages 491-503

  Nutt, Samuel E ^a,b   Chang, Eun Ah ^c   Suhr, Steven T ^c   Schlosser, Laura O ^a,b   Mondello, Sarah E ^a,b,d   Moritz, Chet T ^a,d   Cibelli, Jose B ^b,c   Horner, Philip J ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d LARCel   (Spain)

Author keywords

Induced pluripotent stem cells; Neural progenitor cells; Spinal cord injury

Indexed keywords

ADULT ANIMAL; ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; CERVICAL SPINAL CORD INJURY; CONTROLLED STUDY; FEMALE; FETUS; FORELIMB; GLIA CELL; HUMAN; HUMAN CELL; NEURAL STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RAT; SPINAL CORD FUNCTION; SPINAL CORD NERVE CELL; STEM CELL TRANSPLANTATION;

INDUCED PLURIPOTENT STEM CELLS; NEURAL PROGENITOR CELLS; SPINAL CORD INJURY;

ANIMALS; CELL DIFFERENTIATION; CELL SURVIVAL; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MOTOR ACTIVITY; NERVE REGENERATION; NEURAL STEM CELLS; NEUROGENESIS; NEUROGLIA; NEURONS; RATS; RATS, LONG-EVANS; RECOVERY OF FUNCTION; SPINAL CORD INJURIES; STEM CELL TRANSPLANTATION;

EID: 84882746714     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2013.07.010     Document Type: Article

References (67)

1. Adachi K., Suemori H., et al. Role of SOX2 in maintaining pluripotency of human embryonic stem cells. Genes Cells 2010, 15(5):455-470.
2. Alaverdashvili M., Whishaw I.Q. Compensation aids skilled reaching in aging and in recovery from forelimb motor cortex stroke in the rat. Neuroscience 2010, 167(1):21-30.
3. Anderson K.D. Targeting recovery: priorities of the spinal cord-injured population. J. Neurotrauma. 2004, 21(10):1371-1383.
4. Anderson D.K., Beattie M., et al. Recommended guidelines for studies of human subjects with spinal cord injury. Spinal Cord 2005, 43(8):453-458.
5. Anderson A.J., Haus D.L., et al. Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?. Regen. Med. 2011, 6(3):367-406.
6. Anon Prevalence of paralysis Retrieved May 17, 2012. http://www.christopherreeve.org/site/c.mtKZKgMWKwG/b.5184255/k.6D74/Prevalence_of_Paralysis.htm.
7. Back S.A., Tuohy T.M., et al. Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat. Med. 2005, 11(9):966-972.
8. Bass A.H., Baker R. Phenotypic specification of hindbrain rhombomeres and the origins of rhythmic circuits in vertebrates. Brain Behav. Evol. 1997, 50(Suppl. 1):3-16.
9. Ben-Ari Y. Basic developmental rules and their implications for epilepsy in the immature brain. Epileptic Disord. 2006, 8(2):91-102.
10. Brown J.P., Couillard-Despres S., et al. Transient expression of doublecortin during adult neurogenesis. J. Comp. Neurol. 2003, 467(1):1-10.
11. Busch S.A., Silver J. The role of extracellular matrix in CNS regeneration. Curr. Opin. Neurobiol. 2007, 17(1):120-127.
12. Cheng L.C., Pastrana E., et al. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat. Neurosci. 2009, 12(4):399-408.
13. Chong S.Y., Chan J.R. Tapping into the glial reservoir: cells committed to remaining uncommitted. J. Cell Biol. 2010, 188(3):305-312.
14. Cummings B.J., Uchida N., et al. Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(39):14069-14074.
15. de Leon R.D., Tamaki H., et al. Hindlimb locomotor and postural training modulates glycinergic inhibition in the spinal cord of the adult spinal cat. J. Neurophysiol. 1999, 82(1):359-369.
16. Doetsch F. The glial identity of neural stem cells. Nat. Neurosci. 2003, 6(11):1127-1134.
17. Dyer C.A., Benjamins J.A. Organization of oligodendroglial membrane sheets: II. Galactocerebroside:antibody interactions signal changes in cytoskeleton and myelin basic protein. J. Neurosci. Res. 1989, 24(2):212-221.
18. Dyer C.A., Benjamins J.A. Organization of oligodendroglial membrane sheets. I: association of myelin basic protein and 2',3'-cyclic nucleotide 3'-phosphohydrolase with cytoskeleton. J. Neurosci. Res. 1989, 24(2):201-211.
19. Ellis P., Fagan B.M., et al. SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult. Dev. Neurosci. 2004, 26(2-4):148-165.
20. Fawcett J.W., Curt A., et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord 2007, 45(3):190-205.
21. Fehlings M.G., Vawda R. Cellular treatments for spinal cord injury: the time is right for clinical trials. Neurotherapeutics 2011, 8(4):704-720.
22. Fujimoto Y., Abematsu M., et al. Treatment of a mouse model of spinal cord injury by transplantation of human iPS cell-derived long-term self-renewing neuroepithelial-like stem cells. Stem Cells 2012, 30(6):1163-1173.
23. Gensel J.C., Tovar C.A., et al. Behavioral and histological characterization of unilateral cervical spinal cord contusion injury in rats. J. Neurotrauma 2006, 23(1):36-54.
24. Hennou S., Khalilov I., et al. Early sequential formation of functional GABA(A) and glutamatergic synapses on CA1 interneurons of the rat foetal hippocampus. Eur. J. Neurosci. 2002, 16(2):197-208.
25. Hofstetter C.P., Holmstrom N.A., et al. Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat. Neurosci. 2005, 8(3):346-353.
26. Horner P.J., Stokes B.T. Fetal transplantation following spinal contusion injury results in chronic alterations in CNS glucose metabolism. Exp. Neurol. 1995, 133(2):231-243.
27. Houle J.D., Tessler A. Repair of chronic spinal cord injury. Exp. Neurol. 2003, 182(2):247-260.
28. Hu B.Y., Zhang S.C. Differentiation of spinal motor neurons from pluripotent human stem cells. Nat. Protoc. 2009, 4(9):1295-1304.
29. Ikegami T., Nakamura M., et al. Chondroitinase ABC combined with neural stem/progenitor cell transplantation enhances graft cell migration and outgrowth of growth-associated protein-43-positive fibers after rat spinal cord injury. Eur. J. Neurosci. 2005, 22(12):3036-3046.
30. Iwanami A., Kaneko S., et al. Transplantation of human neural stem cells for spinal cord injury in primates. J. Neurosci. Res. 2005, 80(2):182-190.
31. Jensen M.B., Yan H., et al. Survival and differentiation of transplanted neural stem cells derived from human induced pluripotent stem cells in a rat stroke model. J. Stroke Cerebrovasc. Dis. 2011, 22(4):304-308.
32. Kang P., Lee H.K., et al. Sox9 and NFIA coordinate a transcriptional regulatory cascade during the initiation of gliogenesis. Neuron 2012, 74(1):79-94.
33. Karimi-Abdolrezaee S., Eftekharpour E., et al. Synergistic effects of transplanted adult neural stem/progenitor cells, chondroitinase, and growth factors promote functional repair and plasticity of the chronically injured spinal cord. J. Neurosci. 2010, 30(5):1657-1676.
34. Keirstead H.S., Nistor G., et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J. Neurosci. 2005, 25(19):4694-4705.
35. Khaing Z.Z., Milman B.D., et al. High molecular weight hyaluronic acid limits astrocyte activation and scar formation after spinal cord injury. J. Neural. Eng. 2011, 8(4):046033.
36. Krencik R., Weick J.P., et al. Specification of transplantable astroglial subtypes from human pluripotent stem cells. Nat. Biotechnol. 2011, 29(6):528-534.
37. Kumagai G., Okada Y., et al. Roles of ES cell-derived gliogenic neural stem/progenitor cells in functional recovery after spinal cord injury. PLoS One 2009, 4(11):e7706.
38. Kwon B.K., Hillyer J., et al. Translational research in spinal cord injury: a survey of opinion from the SCI community. J. Neurotrauma 2010, 27(1):21-33.
39. Li X.J., Du Z.W., et al. Specification of motoneurons from human embryonic stem cells. Nat. Biotechnol. 2005, 23(2):215-221.
40. Lu P., Wang Y., et al. Long-distance growth and connectivity of neural stem cells after severe spinal cord injury. Cell 2012, 150(6):1264-1273.
41. Mitsui T., Shumsky J.S., et al. Transplantation of neuronal and glial restricted precursors into contused spinal cord improves bladder and motor functions, decreases thermal hypersensitivity, and modifies intraspinal circuitry. J. Neurosci. 2005, 25(42):9624-9636.
42. Nash M.S. Known and plausible modulators of depressed immune functions following spinal cord injuries. J. Spinal Cord. Med. 2000, 23(2):111-120.
43. Nori S., Okada Y., et al. Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(40):16825-16830.
44. Ogawa Y., Sawamoto K., et al. Transplantation of in vitro-expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats. J. Neurosci. Res. 2002, 69(6):925-933.
45. Okada S., Ishii K., et al. In vivo imaging of engrafted neural stem cells: its application in evaluating the optimal timing of transplantation for spinal cord injury. FASEB J. 2005, 19(13):1839-1841.
46. Pankratz M.T., Li X.J., et al. Directed neural differentiation of human embryonic stem cells via an obligated primitive anterior stage. Stem Cells 2007, 25(6):1511-1520.
47. Powers B.E., Lasiene J., et al. Axonal thinning and extensive remyelination without chronic demyelination in spinal injured rats. J. Neurosci. 2012, 32(15):5120-5125.
48. Rhee Y.H., Ko J.Y., et al. Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease. J. Clin. Invest. 2011, 121(6):2326-2335.
49. Robel S., Berninger B., et al. The stem cell potential of glia: lessons from reactive gliosis. Nat. Rev. Neurosci. 2011, 12(2):88-104.
50. Salazar D.L., Uchida N., et al. Human neural stem cells differentiate and promote locomotor recovery in an early chronic spinal cord injury NOD-scid mouse model. PLoS One 2010, 5(8):e12272.
51. Schallert T., Fleming S.M., et al. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 2000, 39(5):777-787.
52. Scholzen T., Gerdes J. The Ki-67 protein: from the known and the unknown. J. Cell. Physiol. 2000, 182(3):311-322.
53. Schwab M.E., Bartholdi D. Degeneration and regeneration of axons in the lesioned spinal cord. Physiol. Rev. 1996, 76(2):319-370.
54. Scott C.E., Wynn S.L., et al. SOX9 induces and maintains neural stem cells. Nat. Neurosci. 2010, 13(10):1181-1189.
55. Sekhon L.H., Fehlings M.G. Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine (Phila Pa 1976) 2001, 26(24 Suppl.):S2-S12.
56. Silver J., Miller J.H. Regeneration beyond the glial scar. Nat. Rev. Neurosci. 2004, 5(2):146-156.
57. Spinal Cord Injury Facts and Figures at a Glance Retrieved May 17, 2012. https://www.nscisc.uab.edu/PublicDocuments/nscisc_home/pdf/Facts%202011%20Feb%20Final.pdf.
58. Stolt C.C., Lommes P., et al. The Sox9 transcription factor determines glial fate choice in the developing spinal cord. Genes Dev. 2003, 17(13):1677-1689.
59. Suhr S.T., Chang E.A., et al. Telomere dynamics in human cells reprogrammed to pluripotency. PLoS One 2009, 4(12):e8124.
60. Tetzlaff W., Okon E.B., et al. A systematic review of cellular transplantation therapies for spinal cord injury. J. Neurotrauma 2011, 28(8):1611-1682.
61. Tillakaratne N.J., Mouria M., et al. Increased expression of glutamate decarboxylase (GAD(67)) in feline lumbar spinal cord after complete thoracic spinal cord transection. J. Neurosci. Res. 2000, 60(2):219-230.
62. Tillakaratne N.J., de Leon R.D., et al. Use-dependent modulation of inhibitory capacity in the feline lumbar spinal cord. J. Neurosci. 2002, 22(8):3130-3143.
63. Tsuji O., Miura K., et al. Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(28):12704-12709.
64. Tyzio R., Represa A., et al. The establishment of GABAergic and glutamatergic synapses on CA1 pyramidal neurons is sequential and correlates with the development of the apical dendrite. J. Neurosci. 1999, 19(23):10372-10382.
65. Vaccarino F.M., Fagel D.M., et al. Astroglial cells in development, regeneration, and repair. Neuroscientist 2007, 13(2):173-185.
66. Yuan S.H., Martin J., et al. Cell-surface marker signatures for the isolation of neural stem cells, glia and neurons derived from human pluripotent stem cells. PLoS One 2011, 6(3):e17540.
67. Zhao R., Daley G.Q. From fibroblasts to iPS cells: induced pluripotency by defined factors. J. Cell. Biochem. 2008, 105(4):949-955.